Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria

The aim of this study is to evaluate the effect of the introduction of biosimilars in Bulgaria on the prices and utilization of biologic disease modifying antirheumatic drugs (bDMARD). It is a combined qualitative and quantitative analysis of time of entry of biosimilars on the national market and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachkov, Konstantin, Mitkova, Zornitsa, Boyadzieva, Vladimira, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829887/
https://www.ncbi.nlm.nih.gov/pubmed/33466766
http://dx.doi.org/10.3390/ph14010064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829887/
https://www.ncbi.nlm.nih.gov/pubmed/33466766
http://dx.doi.org/10.3390/ph14010064

Ejemplares similares